CD8A and HIV-1 infection: Previous results suggest that MVA specially induce IL-12p40 (IL12β gene) [18], [49], thus allowing MDDC to maturate and subsequently to develop an enhanced CD8+ T cell response [64], [65], which is recommended for a vaccine against HIV-1 infection [66], [67].